NCT02790047

Brief Summary

The aim of this study to investigate the efficacy of a home-base exercise program with a new conical PEP device on physical performance and health related quality of life in COPD patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable chronic-obstructive-pulmonary-disease

Timeline
Completed

Started Oct 2016

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 2, 2016

Completed
4 months until next milestone

First Posted

Study publicly available on registry

June 3, 2016

Completed
4 months until next milestone

Study Start

First participant enrolled

October 1, 2016

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2018

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2018

Completed
Last Updated

October 31, 2016

Status Verified

October 1, 2016

Enrollment Period

1.3 years

First QC Date

February 2, 2016

Last Update Submit

October 27, 2016

Conditions

Keywords

Chronic Obstructive Pulmonary DiseaseExercise TherapyPositive Expiratory PressurePhysical FitnessQuality of Life

Outcome Measures

Primary Outcomes (1)

  • Change of 6 minute walk distance (6MWD)

    The 6MWD represents physical performance of COPD pateints.

    baseline, post home-base exercise program at 8th weeks and follow up at 5th months

Secondary Outcomes (51)

  • Change of St George's Respiratory Questionnaire (SGRQ) score

    baseline, post home-base exercise program at 8th weeks and follow up at 5th months

  • Incremental sport marching exercise test (ISMT)

    baseline

  • Change of endurance exercise time of endurance sport marching exercise test (ESMT)

    baseline, post home-base exercise program at 8th weeks and follow up at 5th months

  • Change of resting inspiratory capacity (IC)

    baseline, post home-base exercise program at 8th weeks and follow up at 5th months

  • Change of end exercise inspiratory capacity in ESMT (IC-ESMT)

    baseline, post home-base exercise program at 8th weeks and follow up at 5th months

  • +46 more secondary outcomes

Study Arms (2)

Home-base exercise

ACTIVE COMPARATOR

Patients will receive intervention as following 1. A home-base exercise program 2. Health education 3. Breathing strategies for self secretion clearance 4. The medication following the COPD GOLD guidelines (2015)

Other: A home-base exercise programOther: Health educationOther: ฺBreathing strategies for self secretion clearanceDrug: The medication following the COPD GOLD guidelines (2015)

Home-base exercise with a PEP mask

EXPERIMENTAL

Patients will receive intervention as following 1. A home-base exercise program with using a non-re-breathing face mask with conical-PEP device during an interval endurance spot marching exercise 2. Health education 3. Breathing strategies for self secretion clearance 4. The medication following the COPD GOLD guidelines (2015)

Device: A non-re-breathing face mask with conical-PEP deviceOther: A home-base exercise programOther: Health educationOther: ฺBreathing strategies for self secretion clearanceDrug: The medication following the COPD GOLD guidelines (2015)

Interventions

Participant will use a non-re-breathing face mask with conical-PEP device during an interval endurance spot marching exercise.

Home-base exercise with a PEP mask

Duration of the program is 8 weeks A frequency of exercise session is 3 to 5 sessions per week A content of each exercise session includes 1. Stretching exercise (shoulder, trunk and leg muscles) to warm up for 5 to 10 minutes 2. Interval endurance exercise using a spot marching movement for 30 to 40 minutes. In each phase of spot marching exercise, patients will perform the exercise from 0 to 3 or 4 score of 10 score of a modified dyspnea Borg scale, they will record exercise the exercise duration time. Then, they will be required to rest until a modified dyspnea Borg scale \< 1 score. Next, they will perform the next interval of spot marching exercise with the same protocol. 3. Stretching exercise (shoulder, trunk and leg muscles) to cool down for 5 to 10 minutes

Home-base exerciseHome-base exercise with a PEP mask

Health education include 1. Knowledge of COPD disease 2. Smoking status and smoking cessation 3. Medication correctly 4. Self dyspnea management 5. Basic nutrition for COPD

Home-base exerciseHome-base exercise with a PEP mask

Using a modified active cycle breathing technique (mACBT) include 1. Control breathing 2. Pursed lip breathing (PLB) 3. Slow inhale with sustain thoracic expansion for 3 sec and exhale with PLB technique 4. Force expiratory technique (FET) with low to medium lung volume 5. Huffing or coughing

Home-base exerciseHome-base exercise with a PEP mask

Patients will receive medications following the COPD GOLD guidelines (2015). The medication names were listed below 1. Bata 2 agonist (short acting); Salbutamol (oral or inhaler), Terbutaline (oral) 2. Bata 2 agonist (long acting); Bambuterol (oral), Procaterol (oral), Salmeterol (inhaler), Formoterol (inhaler) 3. Xanthine derivative (sustained release theophylline) 4. Anticholinergic; Tiotropium(inhaler), Ipratropium bromide (inhaler) 5. Corticosteroids; Beclomethasone (inhaler), Budesonide(inhaler), Fluticasone(inhaler) 6. Combined anticholinergic+ Beta 2-agonist; Ipratropium+fenoterol (inhaler), Ipratropium+salbutamol (inhaler) 7. Combined Beta 2-agonist+ corticosteroids; Formoterol+ Budesonide(inhaler), Salmeterol+ Fluticasone(inhaler)

Home-base exerciseHome-base exercise with a PEP mask

Eligibility Criteria

Age35 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • COPD patients (with FEV1 ≤70% predicted)

You may not qualify if:

  • Exacerbate within a month prior, which was a cause of admission to the hospital emergency room or been admitted to hospital.
  • Are changed medicines within a month ago.
  • Have been used home oxygen therapy.
  • Have musculoskeletal or neuromuscular problem affecting balance and walking. and spot marching exercise.
  • Using walking aid device.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

School of Physical Therapy, Faculty of Associated Medical Sciences

Khon Kaen, Changwat Khon Kaen, 40002, Thailand

NOT YET RECRUITING

Srinagarind Hospital

Khon Kaen, Changwat Khon Kaen, 40002, Thailand

RECRUITING

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Chulee U Jones, Ph.D., PT

    Khon Kaen University

    STUDY DIRECTOR
  • Chatchai Phimphasak, M.Sc, PT

    Khon Kaen University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Chatchai Phimphasak, M.Sc., PT

CONTACT

Chulee U jones, Ph.D., PT

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 2, 2016

First Posted

June 3, 2016

Study Start

October 1, 2016

Primary Completion

January 1, 2018

Study Completion

May 1, 2018

Last Updated

October 31, 2016

Record last verified: 2016-10

Locations